|
|
The family of Benephit® Infusion Systems available from FlowMedica provides physicians a means of administering Targeted Renal Therapy (TRT™) - the direct delivery of therapeutic agents to the kidneys via the renal arteries. Numerous medical centers throughout the United States have initiated investigator-sponsored studies to evaluate clinical performance of the Benephit System in a variety of clinical settings including the catheterization laboratory, the surgical suite, the CCU and ICU. For additional information on investigator-sponsored studies, click here.
To monitor general use of the Benephit Systems outside of formal investigator-sponsored clinical studies, FlowMedica is sponsoring the Be-RITe! (Benephit System Renal Infusion Therapy) International Registry. This retrospective, post-market, multi-center surveillance effort is designed to track and quantify real-world usage patterns of the system. For additional Be-RITe! International Registry information, click here.
|
|
|
 |
